Emyria – Levin Health’s Athlete Support Program

The Levin Health’s Athlete Support Program (LASP) was designed to support former athletes experiencing chronic pain from their time in elite sports and for whom traditional treatments were ineffective. The observational program, conducted by Emyria’s Emerald Clinics data registry, monitored and measured the effectiveness, safety and tolerability of medicinal cannabis treatment for retired athletes.

Participants Cohort

Twenty participants were selected for this program. The participants reported that substantial pain was affecting their daily physical functioning. Patient ages ranged from 34 to 79 years.

Medication

Patients were prescribed:

• CBD-dominant medicinal cannabis oil and/or
• CBD:THC-balanced medicinal cannabis oil

Data Analysis

At the end of the program, the data support the tolerability of treatment with medicinal cannabis oil. Additionally, participants self-reported an improvement in:

• Physical functioning
• Stress levels
• Sleep

By investing in Australian research to clinically validate the real-world efficacy of cannabis medicines for the treatment of chronic pain, Levin Health is committed to supporting patients through access and advocacy for medicinal cannabis.

Disclaimer: The program involved medicinal cannabis products which are not registered on the Australian Register for Therapeutic Goods (ARTG), and can only be accessed via the Special Access Scheme (SAS, category A or B), or the Authorised Prescriber scheme. The use of any unregistered product is at the discretion of the prescribing physician.